With cancer incidence rates continuing to increase and occurrence of resistance in drug
treatment, there is a pressing demand to find safer and more effective anticancer strategy for …

Non-coding RNAs, including long non-coding RNAs (lncRNAs), microRNAs (miRNAs), and
circular RNAs (circRNAs), are being studied extensively in a variety of fields. Their roles in …

Cancer comprises a heterogeneous disease, characterized by diverse features such as
constitutive expression of oncogenes and/or downregulation of tumor suppressor genes …

CD4+ T cells are effector T cells (Teffs) produced by the differentiation of initial T cells in
peripheral lymphoid tissue after being attacked by antigens, and have an indispensable role …

Enhanced activation of the transcription factor MYC and of the receptor tyrosine kinase MET
are among the events frequently occurring in hepatocellular carcinoma (HCC). Both genes …

Rationale: Cisplatin-based chemotherapy is the first-line treatment for late-stage head and
neck squamous cell carcinoma (HNSCC). However, resistance to cisplatin has become a …

Oral squamous cell carcinoma (OSCC) represents 90% of malignant epithelial cancer that
occurs in the oral cavity. The c-Myc factor is expressed in multiple types of cancer …

Head and neck cancer ranks as the sixth most prevalent malignancy, constituting 5% of all
cancer cases. Its inconspicuous onset often leads to advanced stage diagnoses, prompting …

Kirsten rat sarcoma viral oncogene homologue (KRAS) is a frequent oncogenic driver of
solid tumors, including non-small cell lung cancer (NSCLC). The treatment and outcomes of …

Long noncoding RNAs (lncRNAs) play fundamental roles in cancer development; however,
the underlying mechanisms for a large proportion of lncRNAs in pancreatic ductal …